| Intraoperative Fluid Management of Liposuction , Cardiometry Versus Rohrich Formula (NCT05402982) | Ahmed Abdel Wahed Ali | 2022-06-25 |
| Evaluating the Performance and Safety of the Medical Device Plenhyage® in the Treatment of Dermal Tissue Defects (NCT05239117) | I.R.A. Istituto Ricerche Applicate S.p.A. | 2022-03-30 |
| Evaluating the Performance and Safety of the Medical Device Auralya® in the Treatment of Facial Dermal Tissue Defects (NCT05239130) | I.R.A. Istituto Ricerche Applicate S.p.A. | 2022-03-21 |
| Evaluating the Performance and Safety of the Medical Device Janesse in the Treatment of Facial Dermal Tissue Defects (NCT05239156) | I.R.A. Istituto Ricerche Applicate S.p.A. | 2022-03-14 |
| Exploratory Study of the Relationships Between the Biomarkers of Inflammation, Lipidome and Insulin Resistance and Disorders of Glycemic Regulation in a Cohort of Insulin-resistant Subjects Due to Excess Weight or Dunnigan's Lipodystrophy (NCT05424913) | Centre Hospitalier Universitaire de la Réunion | 2021-08-17 |
| Effect of Berberine on Metabolic Syndrome, Efficacy and Safety in Combination With Antiretroviral Therapy in PLWH. (NCT04860063) | Hospital Civil de Guadalajara | 2021-04-01 |
| Hemoglobin Level, Coagulopathy Profile and Electrolyte Balance (NCT04656054) | Alaa Hassan M. Elhawary | 2020-11-01 |
| Low Energy Diet and Familial Partial Lipodystrophy (NCT03900286) | Cambridge University Hospitals NHS Foundation Trust | 2020-01-16 |
| The PREFORM Study: Rotational Fractional Resection for Submental Contouring (NCT03966924) | Recros Medica, Inc. | 2019-03-20 |
| Insulin Regulated Amino Peptidase in Patients With Familial Lipodystrophy of DUNNIGAN (NCT04578379) | Centre Hospitalier Universitaire de la Réunion | 2019-03-01 |
| Growth Hormone Dynamics and Cardiac Steatosis in HIV (NCT03826160) | Massachusetts General Hospital | 2019-01-30 |
| CONFORM: Rotational Fractional Resection for Submental Contouring (NCT03407313) | Recros Medica, Inc. | 2018-01-08 |
| Shock Waves for Treatment of Gynoid Lipodystrophy and Localized Fat (NCT03275259) | Indústria Brasileira Equipamentos Médicos - IBRAMED | 2017-04-03 |
| The Cleveland Cardiometabolic Cohort (NCT03059121) | University Hospitals Cleveland Medical Center | 2016-09-01 |
| Prevalence of Lipodystrophy Syndrome and Its Role as Cause of Metabolic Disturbances (NCT02614027) | Asociacion para el Estudio de las Enfermedades Infecciosas | 2016-02-01 |
| Efficacy, Safety and Tolerability of ISIS 304801 in People With Partial Lipodystrophy With an Open-Label Extension (NCT02639286) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2015-12-23 |
| Role of Mesenchymal Stem Cells in Fat Grafting (NCT02494752) | King Edward Medical University | 2015-08-01 |
| Clinical Evaluation of Venus Versa Octipolar Applicator for Reduction of Abdomen Circumference (NCT02492997) | Venus Concept | 2015-05-14 |
| Factors Mediating Gut Microbiota Dysbiosis and Metabolic Disease in HIV Patients. (NCT02258685) | University of Colorado, Denver | 2014-11-01 |
| Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy (NCT02262806) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2014-10-14 |
| Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy (NCT02262832) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2014-10-09 |
| Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy Volunteers (NCT02647853) | Topokine Therapeutics, Inc. | 2014-10-01 |
| Identification of a New Gene Involved in Hereditary Lipodystrophy (NCT02056912) | University Hospital, Bordeaux | 2014-01-01 |
| Lipodystrophy Connect Patient Registry (NCT02577952) | PatientCrossroads | 2014-01-01 |
| Quality of Life, Sleep, and Biomarkers in People With HIV/AIDS (NCT03445351) | JULIANY DE SOUZA ARAUJO | 2013-01-20 |
| Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy (NCT01679197) | University of Michigan | 2012-10-08 |
| Egrifta Replacement and Sleep Disordered Breathing (NCT01788462) | Johns Hopkins University | 2012-05-01 |
| Metabolic Abnormalities in HIV-infected Persons (NCT01612858) | Tufts Medical Center | 2011-06-01 |
| Adipocyte, Insulin-resistance and Immunity : Evaluation of Interleukin-7 in Lipodystrophy, Diabetes and Obesity (NCT01784289) | University Hospital, Lille | 2010-06-01 |
| Exercise for Patients With HIV Infections (NCT00910936) | Charite University, Berlin, Germany | 2009-05-01 |
| An Open-Label Treatment Protocol to Provide Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With Lipodystrophy (NCT00677313) | Bristol-Myers Squibb | 2009-03-01 |
| Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy (NCT00865007) | Fundacion SEIMC-GESIDA | 2008-12-01 |
| Raltegravir Therapy for Women With HIV and Fat Accumulation (NCT00656175) | University of California, Los Angeles | 2008-09-01 |
| Autologous Adipose-Derived Stem Cell Transplantation in Patients With Lipodystrophy (NCT00715546) | Irmandade Santa Casa de Misericórdia de Porto Alegre | 2007-10-01 |
| TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy (NCT00608023) | Theratechnologies | 2007-08-01 |
| Corticosteroid-induced Lipodystrophy and Adipokines (NCT00822042) | Assistance Publique - Hôpitaux de Paris | 2006-08-01 |
| SHARE: Simple HAART With Abacavir, Reyataz, and Epivir (NCT00426296) | Clinical Alliance for Research & Education - Infectious Diseases, LLC. | 2006-08-01 |
| TH9507 in Patients With HIV-Associated Lipodystrophy (NCT00123253) | Theratechnologies | 2005-06-01 |
| Observational Study of Fat Loss in HIV Infected Adults Taking Nucleoside Reverse Transcriptase Inhibitors (NRTIs) (NCT00119405) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-04-01 |
| Effectiveness of Nucleoside Supplementation or Switch to Tenofovir in Reversing Fat Loss in HIV Infected Adults (NCT00119379) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-04-01 |
| The Effect of Low-Dose Human Growth Hormone Therapy in HIV Infected Patients (NCT00119769) | Hvidovre University Hospital | 2005-02-01 |
| White Light Scanning to Aid Body Contouring: A Pilot Project (NCT01093950) | Eastern Virginia Medical School | 2005-01-01 |
| Exercise and Pioglitazone for HIV-Metabolic Syndromes (NCT00639457) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2005-01-01 |
| Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects (NCT00192621) | Kirby Institute | 2004-11-01 |
| Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) Patients (NCT00082628) | EMD Serono | 2004-05-28 |
| Proton Magnetic Resonance Spectroscopy (1H MRS) in Evaluating the Bone Marrow, Muscle and Adipose Tissue on Normal and Human Immunodeficiency Virus Infected Subjects (NCT00172315) | National Taiwan University Hospital | 2003-12-01 |
| A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth (NCT00069004) | National Institute of Allergy and Infectious Diseases (NIAID) | 2003-10-01 |
| Study to Evaluate Changes in Limb Fat When Switching From a Thymidine Analogue (NCT00647946) | Gilead Sciences | 2003-02-01 |
| Therapeutic Approaches to HAART-Induced Lipodystrophy (NCT00461552) | University of Texas Southwestern Medical Center | 2003-01-01 |
| Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients (NCT00028314) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-03-01 |
| Leptin to Treat Lipodystrophy (NCT00025883) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2001-10-01 |
| Pravastatin for Hyperlipidaemia in HIV. (NCT00227500) | Kirby Institute | 2001-07-01 |
| A Study to Determine How and Why HIV-Infected Subjects on Anti-viral Treatment Develop Lipodystrophy (NCT00006190) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2000-11-01 |
| The Effect of Anti-HIV Treatment on Body Characteristics of HIV-Infected Children (NCT00006064) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-06-01 |
| Observational Study of Changes in Fat Distribution and Blood Metabolites in HIV Infected Adults (NCT00331448) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-06-01 |
| Leptin to Treat Lipodystrophy (NCT00005905) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2000-06-01 |
| A Study of Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive Patients (NCT00005764) | Glaxo Wellcome | 2000-05-01 |
| Study of Alpha-2 Adrenergic Receptor Dysfunction in Regional Lipoatrophy (NCT00004329) | National Center for Research Resources (NCRR) | 1999-11-01 |
| Metabolism and Body Shape of Healthy Children and Children With Chronic Infections (NCT00001142) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1999-10-01 |
| Underlying Abnormalities in Fat and Muscle Leading to Lipodystrophy Syndrome (NCT00006185) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1999-09-01 |
| The Effects of Anabolic Steroids and Protease Inhibitors on People Living With HIV/AIDS (NCT00202241) | Queen's University | 1999-09-01 |
| Changing to Nonprotease Inhibitor Treatment to Improve Side Effects (NCT00021463) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs (NCT00017758) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Perceived Changes in Body Build and Image in Patients Who Are Now Taking or Recently Have Stopped Taking Anti-HIV Drugs (NCT00006290) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood Lipids (NCT00006412) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Clinical Trial to Determine the Efficacy of Sculptra™ Dermal Filler for the Correction of Contour Deformities Caused by Lipoatrophy (NCT00360139) | Dermatology Cosmetic Laser Medical Associates of La Jolla, Inc. | |
| Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities (NCT00015691) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Expanded Access to REGN4461 for Patients With Diseases Associated With Deficient Leptin Signaling (NCT04710056) | Regeneron Pharmaceuticals | |